Ventas, Inc.
VTRReal Estate Reit Healthcare Facilities
Ventas, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $5.8 billion, up 18.5% from fiscal 2024.
- Revenue
- +23.0%
- EPS
- −7.14%
- Free cash flow
- +20.5%
- Total debt
- −1.07%
Quarter to September 2026, against a year earlier
After hours trading: 86.55, down 0.02%, last trade 7:28pm Eastern.
Follow VTR
Alert me
Ventas, Inc. (VTR) P/B ratio
As of Nov 20, 2026, Ventas, Inc. (VTR) trades at a P/B ratio of 2.8×. Over the past ten years it has ranged from 0.6× (March 2020) to 3.3× (July 2026); the current reading is higher than 91% of that period. That is above the Reit Healthcare Facilities industry median of 1.6× and above the Real Estate sector median of 1.0×.
P/B ratio, daily
Embed this chart
Annual newest first
| Period | P/B ratio | Change |
|---|---|---|
| FY2025 | 2.8× | 24.95% |
| FY2024 | 2.2× | 5.18% |
| FY2023 | 2.1× | 20.05% |
| FY2022 | 1.8× | (0.80%) |
| FY2021 | 1.8× | 0.35% |
| FY2020 | 1.8× | (11.10%) |
| FY2019 | 2.0× | (1.39%) |
| FY2018 | 2.0× | 4.62% |
| FY2017 | 1.9× | (4.51%) |
| FY2016 | 2.0× | 5.04% |
Quarterly newest first
| Period | P/B ratio | Change |
|---|---|---|
| Sep 2026 | 2.8× | (6.77%) |
| Jun 2026 | 3.0× | 0.03% |
| Mar 2026 | 3.0× | 5.59% |
| Dec 2025 | 2.8× | 8.91% |
| 43 more quarters | Free account |
Against its own ten years
P/B ratio against peers
| Company | P/B ratio |
|---|---|
| DOC Healthpeak Properties, Inc. compare | 1.2× |
| NHI National Health Investors, Inc. compare | 1.4× |
| HR Healthcare Realty Trust Incorporated compare | 1.6× |
| CTRE CareTrust REIT, Inc. compare | 1.7× |
| SBRA Sabra Healthcare REIT, Inc. compare | 1.8× |
| AHR American Healthcare REIT, Inc. compare | 2.2× |
| OHI Omega Healthcare Investors, Inc. compare | 2.4× |
| VTR Ventas, Inc. | 2.8× |
| WELL Welltower Inc. compare | 3.5× |
| Reit Healthcare Facilities industry median | 1.6× |
| Real Estate sector median | 1.0× |
| Market median | 1.6× |
What P/B ratio is
Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.
Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))
More on VTR
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- The full statement